The Procter & Gamble Company (NYSE:PG) Shares Sold by Monterey Private Wealth Inc.

Monterey Private Wealth Inc. reduced its holdings in The Procter & Gamble Company (NYSE:PG) by 6.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,114 shares of the company’s stock after selling 200 shares during the quarter. Monterey Private Wealth Inc.’s holdings in Procter & Gamble were worth $505,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of PG. HighPoint Advisor Group LLC purchased a new position in Procter & Gamble in the 4th quarter valued at approximately $17,696,000. Dfpg Investments LLC increased its stake in Procter & Gamble by 1.7% in the 4th quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after purchasing an additional 424 shares in the last quarter. Campbell Wealth Management increased its stake in Procter & Gamble by 13.1% in the 4th quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock valued at $291,000 after purchasing an additional 231 shares in the last quarter. Herold Advisors Inc. increased its stake in Procter & Gamble by 2.2% in the 4th quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after purchasing an additional 581 shares in the last quarter. Finally, Metis Global Partners LLC increased its stake in Procter & Gamble by 15.7% in the 4th quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after purchasing an additional 15,599 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock opened at $167.73 on Friday. The business’s fifty day moving average price is $164.33 and its 200 day moving average price is $157.89. The stock has a market capitalization of $395.87 billion, a P/E ratio of 27.41, a PEG ratio of 3.42 and a beta of 0.42. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $168.97. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. The company had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.43 billion. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm’s quarterly revenue was up .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.37 earnings per share. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.55 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date was Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is currently 65.85%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on PG shares. Jefferies Financial Group raised their price target on Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research report on Monday, April 22nd. Truist Financial raised Procter & Gamble from a “hold” rating to a “buy” rating and raised their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Barclays raised their price target on Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. StockNews.com downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $169.76.

Insiders Place Their Bets

In other news, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, CEO R. Alexandra Keith sold 855 shares of Procter & Gamble stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $158.50, for a total transaction of $135,517.50. Following the sale, the chief executive officer now directly owns 4,004 shares of the company’s stock, valued at $634,634. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Sundar G. Raman sold 31,924 shares of Procter & Gamble stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares in the company, valued at $3,179,061.90. The disclosure for this sale can be found here. Insiders have sold a total of 154,544 shares of company stock worth $25,413,051 over the last quarter. 0.17% of the stock is owned by corporate insiders.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.